Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureYves NDAMUKUNDA, MUKANOHELI Solange, Eden Enyew Zeleke
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Uric acid and cardiovascular risk
10.1056/nejmra0800885 · 2008
Hyperuricemia and progression of CKD in children and adolescents: The chronic kidney disease in children (CKiD) cohort study
10.1053/j.ajkd.2015.06.015 · 2015
Dietary fructose: from uric acid to a metabolic switch in pediatric metabolic dysfunction-associated steatotic liver disease
10.1080/10408398.2024.2392150 · 2025
Unresolved referenced work
Kept as external metadata until matched
Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies
10.1080/07853890.2022.2083670 · 2022
Uric acid levels in overweight and obese children, and their correlation with metabolic risk factors
10.7759/cureus.70160 · 2024
Age and gender-specific reference intervals for uric acid level in children aged 5–14 years in Southeast Zhejiang Province of China: Hyperuricemia in children may need redefinition
10.3389/fped.2021.560720 · 2021
Reference interval of serum uric acid among healthy children and adolescents in Nanjing, China, and influencing factors
10.1080/07853890.2025.2531249 · 2025
Pediatrics hyperuricemia in clinical practice: A retrospective analysis in 1753 children and adolescents with hyperuricemia
10.1016/j.jbspin.2024.105796 · 2025
Changes in serum urate and urate excretion with age
10.1053/j.ackd.2012.07.010 · 2012
Fructose and uric acid: Major mediators of cardiovascular disease risk starting at pediatric age
10.3390/ijms21124479 · 2020
Genetic background of selected hyperuricemia causing gout with pediatric onset
10.1016/j.jbspin.2025.105884 · 2025
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
10.1186/s13075-019-1860-8 · 2019
Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents
10.1161/circulationaha.106.657627 · 2007
Association of serum uric acid concentration with components of pediatric metabolic syndrome: A systematic review and meta-analysis
10.4103/jrms.jrms_733_19 · 2020
Association between serum uric acid and metabolic syndrome components in prepubertal obese children (Tanner Stage I) from Nuevo León, Mexico - a preliminary study
10.1186/s40608-017-0160-6 · 2017
Uric acid reference values: report on 1750 healthy Brazilian children and adolescents
10.1038/s41390-020-01185-9 · 2021
Elevated uric acid levels link to a higher cardiometabolic risk profile in adolescents
10.1007/s40618-025-02798-9 · 2026
Childhood uric acid predicts adult blood pressure
10.1161/01.hyp.0000150783.79172.bb · 2005
Association between serum levels of uric acid and blood pressure tracking in childhood
10.1093/ajh/hpx037 · 2017
Uric acid and arterial stiffness in children and adolescents: Role of insulin resistance and blood pressure
10.3389/fcvm.2022.978366 · 2022
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial
10.1001/jama.300.8.924 · 2008
Uric acid reduction rectifies prehypertension in obese adolescents
10.1161/hypertensionaha.112.196980 · 2012
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism
10.1152/ajprenal.00283.2001 · 2002
Factors influencing serum uric acid levels and their impact on cardiovascular risk in patients with pediatric chronic kidney disease
10.1007/s00467-025-06961-5 · 2026
The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper
10.1080/10408363.2017.1379945 · 2017
Childhood and adolescent obesity: A review
10.3389/fped.2020.581461 · 2021
Obesity: Prevalence, causes, consequences, management, preventive strategies and future research directions
10.1016/j.metop.2025.100375 · 2025
Clinical practice consensus statement 2025: Management of hyperuricemia and gout in adolescents
10.1111/1756-185x.70378 · 2025
Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update
10.1016/j.ejim.2026.106727 · 2026
Hyperuricemia and its related diseases: mechanisms and advances in therapy
10.1038/s41392-024-01916-y · 2024
No additional external references are available.